Retour aux projets

13760.1;9 PFFLE-LS

Anti-Myelin-Associated Glycoprotein Neuropathy: Development of a New Diagnostic Assay

Résumé

Anti-Myelin-Associated Glycoprotein Neuropathy: Development of a New Diagnostic Assay

Textes supplémentaires

Abstract

Anti-myelin-associated glycoprotein (MAG) neuropathy is a peripheral demyelinating neuropathy which is caused by IgM autoantibodies recognizing the carbohydrate epitope of MAG. The aim of this project is to chemically synthesize such epitope structures and to develop a new clinical test based on these MAG mimic epitopes to replace the existing BÜHLMANN anti-MAG ELISA based on a MAG antigen purified from human brains. The synthetic epitopes will also be combined with five different ganglioside epitopes (glycolipid structures) of the existing BÜHLMANN GanglioCombi® assay to generate a novel screening method suited for determining any peripheral neuropathies caused by autoantibodies to nerve structures. The simplified, automated production of microtiter plates and the development and validation of a software interpreting the results of this new Ganglio/MAG screening assay will complete the entire test package.

Participants

Beat Ernst

Kontaktperson

beat.ernst@unibas.ch

Universität Basel Beat Ernst Klingelbergstrasse 50 4056 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2011-12-31
Date de fin
2013-12-05
Coûts totaux approuvés
CHF 187000.00
Section
5 KTI
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T115 Medical technology 100.0%